Prot #BTCRC-LUN19-396: A Phase II Study of Adjuvant Treatment with Cisplatin-Based Chemotherapy Plus Concomitant Atezolizumab in Patients with Stage I (Tumors ≥ 4cm), IIA, IIB, and Select IIIA [T3N1, T4N0-1] Resected Non-Small Cell Lung Cancer (NSCLC) and

Project: Research project

Project Details

StatusActive
Effective start/end date10/21/2010/21/23

Funding

  • Hoosier Cancer Research Network, Inc. (Prot #BTCRC-LUN19-396)
  • Genentech, Inc. (Prot #BTCRC-LUN19-396)